Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WesternTheaterCommand
NCT07205250Phase 1Not yet recruiting
- Sponsor
- General Hospital of Western Theater Command of PLA
- Start
- Feb 2026
- Primary completion
- Jan 2028
- Modality
- Orthosteric Ligands
01
Overview
Phase 1, randomised, double-blind trial of aspirin in stroke (3 arms), sponsored by General Hospital of Western Theater Command of PLA. Primary endpoint: Incidence of postoperative stroke at 1 year. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
aspirin
03
Conditions
stroke
Beyond the preview
Go deeper on NCT07205250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07205250.